• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

褪黑素对新生大鼠白内障形成的抑制作用:褪黑素抗氧化作用的证据。

Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin.

作者信息

Abe M, Reiter R J, Orhii P B, Hara M, Poeggeler B

机构信息

Department of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio 78240-7762.

出版信息

J Pineal Res. 1994 Sep;17(2):94-100. doi: 10.1111/j.1600-079x.1994.tb00119.x.

DOI:10.1111/j.1600-079x.1994.tb00119.x
PMID:7869232
Abstract

We evaluated the inhibitory effect of melatonin, a recently discovered scavenger of free radicals, on cataract formation in the newborn rat. The glutathione synthesis inhibitor, buthionine sulfoximine (BSO) (3 mmol/kg), was intraperitoneally injected into newborn rats for 3 consecutive days starting on day 2 after birth. These glutathione depleted rats develop cataracts. Melatonin (4 mg/kg) was injected intraperitoneally into half of the rats once a day beginning at day 2 after birth; the other half of the animals received solvent daily. The incidence of cataract was observed on day 16, after the eyes of the newborn animals had opened. Both reduced glutathione (GSH) and oxidized glutathione (GSSG) levels were measured. Cataracts were observed in all animals (18/18) treated with BSO plus solvent. The incidence of the cataract in the animals cotreated with melatonin was only 6.2% (1/15). Total lenticular glutathione (GSH + GSSG) levels in BSO only treated rats were reduced by 97%. The total glutathione in the lens of the BSO plus melatonin group was significantly higher (by 3%) than that of the BSO only group. The percentage of the total glutathione as GSSG for the BSO plus solvent group was higher than the control value. Cotreatment of BSO injected rats with melatonin (4 mg/kg/day) clearly reduced cataract formation proving that it is directly or indirectly protective against oxidative stress which accompanies glutathione deficiency. The inhibitory effects of melatonin on cataract formation in this study could be due to melatonin's free radical scavenging activity or due to its stimulatory effect on glutathione production.

摘要

我们评估了褪黑素(一种最近发现的自由基清除剂)对新生大鼠白内障形成的抑制作用。谷胱甘肽合成抑制剂丁硫氨酸亚砜胺(BSO)(3 mmol/kg)于新生大鼠出生后第2天开始连续3天腹腔注射。这些谷胱甘肽耗竭的大鼠会发展为白内障。从出生后第2天开始,每天一次对一半的大鼠腹腔注射褪黑素(4 mg/kg);另一半动物每天接受溶剂注射。在新生动物睁眼后的第16天观察白内障的发生率。同时测量还原型谷胱甘肽(GSH)和氧化型谷胱甘肽(GSSG)的水平。接受BSO加溶剂处理的所有动物(18/18)均出现白内障。与褪黑素联合处理的动物中白内障的发生率仅为6.2%(1/15)。仅用BSO处理的大鼠晶状体总谷胱甘肽(GSH + GSSG)水平降低了97%。BSO加褪黑素组晶状体中的总谷胱甘肽明显高于仅用BSO处理的组(高3%)。BSO加溶剂组中作为GSSG的总谷胱甘肽百分比高于对照值。用褪黑素(4 mg/kg/天)对注射BSO的大鼠进行联合处理明显减少了白内障的形成,证明其对伴随谷胱甘肽缺乏的氧化应激具有直接或间接的保护作用。本研究中褪黑素对白内障形成的抑制作用可能是由于褪黑素的自由基清除活性或其对谷胱甘肽产生的刺激作用。

相似文献

1
Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin.褪黑素对新生大鼠白内障形成的抑制作用:褪黑素抗氧化作用的证据。
J Pineal Res. 1994 Sep;17(2):94-100. doi: 10.1111/j.1600-079x.1994.tb00119.x.
2
Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: preventive actions of melatonin.用丁硫氨酸亚砜胺处理的新生大鼠的白内障形成与脂质过氧化:褪黑素的预防作用
J Pineal Res. 1997 Apr;22(3):117-23. doi: 10.1111/j.1600-079x.1997.tb00312.x.
3
In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide.新型抗氧化剂 N-乙酰半胱氨酸酰胺对 L-丁硫氨酸-(S,R)-亚砜诱导白内障的体内抑制作用。
Free Radic Biol Med. 2011 Mar 15;50(6):722-9. doi: 10.1016/j.freeradbiomed.2010.12.017. Epub 2010 Dec 21.
4
Alpha-lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats.
Free Radic Biol Med. 1995 Apr;18(4):823-9. doi: 10.1016/0891-5849(94)00195-p.
5
Stereospecific effects of R-lipoic acid on buthionine sulfoximine-induced cataract formation in newborn rats.R-硫辛酸对丁硫氨酸亚砜亚胺诱导的新生大鼠白内障形成的立体特异性作用。
Biochem Biophys Res Commun. 1996 Apr 16;221(2):422-9. doi: 10.1006/bbrc.1996.0611.
6
Progression of mouse buthionine sulfoximine cataracts in vitro is inhibited by thiols or ascorbate.小鼠丁硫氨酸亚砜胺白内障在体外的进展受到硫醇或抗坏血酸盐的抑制。
Exp Eye Res. 1997 Sep;65(3):341-7. doi: 10.1006/exer.1997.0334.
7
State of sulfhydryl in selenite cataract.亚硒酸盐性白内障中巯基的状态
Toxicol Appl Pharmacol. 1984 Jun 15;74(1):109-15. doi: 10.1016/0041-008x(84)90276-x.
8
Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage.谷胱甘肽酯可预防丁硫氨酸亚砜胺诱导的白内障和晶状体上皮细胞损伤。
Proc Natl Acad Sci U S A. 1989 Nov;86(22):8727-31. doi: 10.1073/pnas.86.22.8727.
9
Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.D,L-丁硫氨酸-S,R-亚砜亚胺对铂在体内对肾脏血红素和血红蛋白代谢影响的促进作用。谷胱甘肽的可能作用。
Biochem Pharmacol. 1990 May 15;39(10):1565-71. doi: 10.1016/0006-2952(90)90522-m.
10
Modulatory effect of glutathione status and antioxidants on methylmercury-induced free radical formation in primary cultures of cerebral astrocytes.谷胱甘肽状态和抗氧化剂对原代培养脑星形胶质细胞中甲基汞诱导的自由基形成的调节作用。
Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):11-22. doi: 10.1016/j.molbrainres.2005.02.006. Epub 2005 Mar 17.

引用本文的文献

1
Research progress on antioxidants and protein aggregation inhibitors in cataract prevention and therapy (Review).抗氧化剂和蛋白聚集抑制剂在白内障防治中的研究进展(综述)。
Mol Med Rep. 2025 Jan;31(1). doi: 10.3892/mmr.2024.13387. Epub 2024 Nov 8.
2
The Therapeutic Trip of Melatonin Eye Drops: From the Ocular Surface to the Retina.褪黑素滴眼液的治疗之旅:从眼表到视网膜
Pharmaceuticals (Basel). 2024 Mar 29;17(4):441. doi: 10.3390/ph17040441.
3
Drug repurposing for reducing the risk of cataract extraction in patients with diabetes mellitus: integration of artificial intelligence-based drug prediction and clinical corroboration.
药物再利用以降低糖尿病患者白内障摘除风险:基于人工智能的药物预测与临床验证的整合
Front Pharmacol. 2023 May 18;14:1181711. doi: 10.3389/fphar.2023.1181711. eCollection 2023.
4
Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?起泡剂的毒理学:褪黑素是一种潜在的治疗选择吗?
Diseases. 2021 Apr 10;9(2):27. doi: 10.3390/diseases9020027.
5
Influence of Circadian Rhythm in the Eye: Significance of Melatonin in Glaucoma.昼夜节律对眼睛的影响:褪黑素在青光眼发病机制中的作用。
Biomolecules. 2021 Feb 24;11(3):340. doi: 10.3390/biom11030340.
6
Current Trends in the Pharmacotherapy of Cataracts.白内障药物治疗的当前趋势
Pharmaceuticals (Basel). 2020 Jan 16;13(1):15. doi: 10.3390/ph13010015.
7
Melatonin Mitigates Mitochondrial Meltdown: Interactions with SIRT3.褪黑素减轻线粒体崩溃:与 SIRT3 的相互作用。
Int J Mol Sci. 2018 Aug 18;19(8):2439. doi: 10.3390/ijms19082439.
8
Pharmacology without drugs.无药物的药理学。
J Optom. 2018 Oct-Dec;11(4):201-202. doi: 10.1016/j.optom.2018.06.002. Epub 2018 Aug 1.
9
Melatonin transport into mitochondria.褪黑素向线粒体的转运。
Cell Mol Life Sci. 2017 Nov;74(21):3927-3940. doi: 10.1007/s00018-017-2616-8. Epub 2017 Aug 21.
10
Melatonin Reduces Cataract Formation and Aldose Reductase Activity in Lenses of Streptozotocin-induced Diabetic Rat.褪黑素可减少链脲佐菌素诱导的糖尿病大鼠晶状体中白内障的形成及醛糖还原酶活性。
Iran J Med Sci. 2016 Jul;41(4):305-13.